Treatment of corticosteroid-resistant thyroid eye disease with subcutaneous tocilizumab

Can J Ophthalmol. 2021 Feb;56(1):66-70. doi: 10.1016/j.jcjo.2020.07.020. Epub 2020 Sep 10.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adrenal Cortex Hormones
  • Antibodies, Monoclonal, Humanized*
  • Graves Ophthalmopathy* / diagnosis
  • Graves Ophthalmopathy* / drug therapy
  • Humans

Substances

  • Adrenal Cortex Hormones
  • Antibodies, Monoclonal, Humanized
  • tocilizumab